{"id":101678,"date":"2026-05-29T18:20:54","date_gmt":"2026-05-29T12:50:54","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=101678"},"modified":"2026-05-29T18:20:55","modified_gmt":"2026-05-29T12:50:55","slug":"vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/","title":{"rendered":"Vivimed Labs Q4 FY26 Results: Net Loss Rs 0.06 Crore, Revenue and Key Financial Highlights"},"content":{"rendered":"<div class=\"meta-block\">\n<p><strong style=\"font-size: revert; color: initial;\"><a href=\"https:\/\/univest.in\/user\/stocks\/vimtalabs\/vimta-labs-ltd-share-price-today\">Vivimed Labs<\/a> Q4 FY26 results<\/strong><span style=\"font-size: revert; color: initial;\"> were declared on May 28, 2026. The company reported a net loss of Loss Rs 0.06 crore for the quarter ended March 31, 2026. Revenue from operations details are available in the BSE\/NSE audited filing. Vivimed Labs is a Specialty Chemicals and Pharma company listed on Indian stock exchanges.<\/span><\/p>\n<\/div>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\">Click Here &#8211; Get Free Investment Predictions<\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#Vivimed_Labs_Q4_FY26_Financial_Highlights\" title=\"Vivimed Labs Q4 FY26 Financial Highlights\">Vivimed Labs Q4 FY26 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#Vivimed_Labs_Q4_FY26_Performance_Analysis\" title=\"Vivimed Labs Q4 FY26 Performance Analysis\">Vivimed Labs Q4 FY26 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#Key_Business_Factors_in_Q4_FY26\" title=\"Key Business Factors in Q4 FY26\">Key Business Factors in Q4 FY26<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#Revenue_and_Volume_Performance\" title=\"Revenue and Volume Performance\">Revenue and Volume Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#Profitability_and_Margin_Trajectory\" title=\"Profitability and Margin Trajectory\">Profitability and Margin Trajectory<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#Sector_and_Macro_Backdrop\" title=\"Sector and Macro Backdrop\">Sector and Macro Backdrop<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#FY27_Outlook\" title=\"FY27 Outlook\">FY27 Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#Vivimed_Labs_Stock_Performance\" title=\"Vivimed Labs Stock Performance\">Vivimed Labs Stock Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#Key_Risks\" title=\"Key Risks\">Key Risks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#Revenue_and_Demand_Risk\" title=\"Revenue and Demand Risk\">Revenue and Demand Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#Margin_and_Cost_Volatility\" title=\"Margin and Cost Volatility\">Margin and Cost Volatility<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#Frequently_Asked_Questions_on_Vivimed_Labs_Q4_FY26_Results\" title=\"Frequently Asked Questions on Vivimed Labs Q4 FY26 Results\">Frequently Asked Questions on Vivimed Labs Q4 FY26 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#What_is_Vivimed_Labs_Q4_FY26_net_profit\" title=\"What is Vivimed Labs Q4 FY26 net profit?\">What is Vivimed Labs Q4 FY26 net profit?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#What_is_Vivimed_Labs_Q4_FY26_revenue\" title=\"What is Vivimed Labs Q4 FY26 revenue?\">What is Vivimed Labs Q4 FY26 revenue?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#When_were_Vivimed_Labs_Q4_FY26_results_declared\" title=\"When were Vivimed Labs Q4 FY26 results declared?\">When were Vivimed Labs Q4 FY26 results declared?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#What_is_the_FY27_outlook_for_Vivimed_Labs\" title=\"What is the FY27 outlook for Vivimed Labs?\">What is the FY27 outlook for Vivimed Labs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#Is_Vivimed_Labs_a_good_stock_to_buy_after_Q4_FY26_results\" title=\"Is Vivimed Labs a good stock to buy after Q4 FY26 results?\">Is Vivimed Labs a good stock to buy after Q4 FY26 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/vivimed-labs-q4-fy26-net-loss-rs-0-06-cr-results\/#What_sector_does_Vivimed_Labs_operate_in\" title=\"What sector does Vivimed Labs operate in?\">What sector does Vivimed Labs operate in?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Vivimed_Labs_Q4_FY26_Financial_Highlights\"><\/span><strong>Vivimed Labs Q4 FY26 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q4 FY26<\/th>\n<th>Q4 FY25<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<tr>\n<td><strong>Revenue from Operations (Rs Cr)<\/strong><\/td>\n<td>BSE Filing<\/td>\n<td>Prior Year<\/td>\n<td>See BSE\/NSE filing<\/td>\n<\/tr>\n<tr>\n<td><strong>Net Loss (PAT) (Rs Cr)<\/strong><\/td>\n<td>0.06<\/td>\n<td>Prior Year<\/td>\n<td>See BSE\/NSE filing<\/td>\n<\/tr>\n<tr>\n<td><strong>Reporting Basis<\/strong><\/td>\n<td colspan=\"3\">Standalone \/ Consolidated (see BSE\/NSE filing)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Data sourced from company filings and public disclosures. Always verify from BSE\/NSE audited filings before investment decisions.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Vivimed_Labs_Q4_FY26_Performance_Analysis\"><\/span><strong>Vivimed Labs Q4 FY26 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Vivimed Labs Q4 FY26 results<\/strong> reflect performance in the January to March 2026 quarter. Revenue details are available in the BSE\/NSE audited filing. Net loss of Loss Rs 0.06 crore reflects the challenges faced during the quarter. Vivimed Labs operates in the Specialty Chemicals and Pharma sector.<\/p>\n<p>India macroeconomic backdrop in Q4 FY26 was characterised by sustained GDP growth above 6.5%, government capex of Rs 11.21 lakh crore for FY27, and the RBI accommodative policy stance. The Specialty Chemicals and Pharma sector benefited from these structural tailwinds during the January to March 2026 quarter.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_in_Q4_FY26\"><\/span><strong>Key Business Factors in Q4 FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_and_Volume_Performance\"><\/span><strong>Revenue and Volume Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Revenue details for <strong>Vivimed Labs<\/strong> Q4 FY26 are available in the BSE\/NSE audited filing declared May 28, 2026. The Specialty Chemicals and Pharma sector benefited from India domestic demand recovery and infrastructure push in FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Profitability_and_Margin_Trajectory\"><\/span><strong>Profitability and Margin Trajectory<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Net loss of Loss Rs 0.06 crore reflects cost pressures and business challenges during the quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Sector_and_Macro_Backdrop\"><\/span><strong>Sector and Macro Backdrop<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India macro environment in Q4 FY26 was characterised by GDP growth above 6.5%, budgeted central capex of Rs 11.21 lakh crore for FY27, and the RBI accommodative policy stance. The Specialty Chemicals and Pharma sector benefited from these structural tailwinds during the quarter ended March 31, 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook\"><\/span><strong>FY27 Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Following the <strong>Vivimed Labs Q4 FY26 results<\/strong>, investors will focus on management guidance for FY27 covering revenue growth, margin improvement, capital allocation, and business strategy. India GDP growth trajectory, domestic demand, and sector-specific catalysts will be key drivers for Vivimed Labs in FY27.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Vivimed_Labs_Stock_Performance\"><\/span><strong>Vivimed Labs Stock Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track live price and daily stock recommendations.<\/p>\n<p>Shares of Vivimed Labs are listed on NSE and BSE. Following the Q4 FY26 results on May 28, 2026, investors should monitor post-results price action and management commentary. Always consult a SEBI-registered financial advisor before investment decisions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks\"><\/span><strong>Key Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_and_Demand_Risk\"><\/span><strong>Revenue and Demand Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Any deceleration in India GDP growth, reduction in government capex, or weakening of private consumption could impact demand for Vivimed Labs products and services in the Specialty Chemicals and Pharma sector in FY27.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Margin_and_Cost_Volatility\"><\/span><strong>Margin and Cost Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Fluctuations in raw material costs, energy prices, and logistics expenses pose margin risks. Any cost escalation without corresponding pricing power could compress profitability.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Vivimed Labs Q4 FY26 results declared on May 28, 2026 showed net loss of Loss Rs 0.06 crore. Investors should monitor management guidance and sector trends before making investment decisions.<\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Verify all data from BSE\/NSE audited filings.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Vivimed_Labs_Q4_FY26_Results\"><\/span><strong>Frequently Asked Questions on Vivimed Labs Q4 FY26 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Vivimed_Labs_Q4_FY26_net_profit\"><\/span><strong>What is Vivimed Labs Q4 FY26 net profit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Vivimed Labs Q4 FY26 net profit was Loss Rs 0.06 crore. Results declared May 28, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Vivimed_Labs_Q4_FY26_revenue\"><\/span><strong>What is Vivimed Labs Q4 FY26 revenue?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Vivimed Labs Q4 FY26 revenue is available in the BSE\/NSE audited filing declared May 28, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"When_were_Vivimed_Labs_Q4_FY26_results_declared\"><\/span><strong>When were Vivimed Labs Q4 FY26 results declared?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Vivimed Labs Q4 FY26 results were declared on May 28, 2026 at the board meeting approving audited financial statements for the quarter and year ended March 31, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_FY27_outlook_for_Vivimed_Labs\"><\/span><strong>What is the FY27 outlook for Vivimed Labs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Following Vivimed Labs Q4 FY26 results, management guidance on revenue growth, margin improvement, and sector dynamics shapes FY27 expectations. Consult a SEBI-registered advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Vivimed_Labs_a_good_stock_to_buy_after_Q4_FY26_results\"><\/span><strong>Is Vivimed Labs a good stock to buy after Q4 FY26 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investment decisions require assessment of fundamentals, valuation, sector outlook, and personal risk tolerance. This content is educational only. Consult a SEBI-registered financial advisor.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_Vivimed_Labs_operate_in\"><\/span><strong>What sector does Vivimed Labs operate in?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Vivimed Labs operates in the Specialty Chemicals and Pharma sector. The company is listed on Indian stock exchanges and declared Q4 FY26 results on May 28, 2026.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is Vivimed Labs Q4 FY26 net profit?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Vivimed Labs Q4 FY26 net profit was Loss Rs 0.06 crore. Results declared May 28, 2026.\"}},{\"@type\":\"Question\",\"name\":\"What is Vivimed Labs Q4 FY26 revenue?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Vivimed Labs Q4 FY26 revenue is available in the BSE\/NSE audited filing declared May 28, 2026.\"}},{\"@type\":\"Question\",\"name\":\"When were Vivimed Labs Q4 FY26 results declared?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Vivimed Labs Q4 FY26 results were declared on May 28, 2026 at the board meeting approving audited financial statements for the quarter and year ended March 31, 2026.\"}},{\"@type\":\"Question\",\"name\":\"What is the FY27 outlook for Vivimed Labs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Following Vivimed Labs Q4 FY26 results, management guidance on revenue growth, margin improvement, and sector dynamics shapes FY27 expectations. Consult a SEBI-registered advisor before investing.\"}},{\"@type\":\"Question\",\"name\":\"Is Vivimed Labs a good stock to buy after Q4 FY26 results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investment decisions require assessment of fundamentals, valuation, sector outlook, and personal risk tolerance. This content is educational only. Consult a SEBI-registered financial advisor.\"}},{\"@type\":\"Question\",\"name\":\"What sector does Vivimed Labs operate in?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Vivimed Labs operates in the Specialty Chemicals and Pharma sector. The company is listed on Indian stock exchanges and declared Q4 FY26 results on May 28, 2026.\"}}]}<\/script><\/div><p><\/p>","protected":false},"excerpt":{"rendered":"<p>Vivimed Labs Q4 FY26 results declared May 28, 2026. Revenue in BSE filing. Net Loss Rs 0.06 Cr. Specialty Chemicals and Pharma. Key highlights and FY27 outlook.<\/p>\n","protected":false},"author":34,"featured_media":102133,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3858,3983],"class_list":["post-101678","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-q4-results","tag-q4-results-2026"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1780059082:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["72"],"rank_math_title":["Vivimed Labs Q4 FY26 Results: Revenue, PAT and Key Highlights"],"rank_math_description":["Vivimed Labs Q4 FY26 results declared May 28, 2026. Revenue in BSE filing. Net Loss Rs 0.06 Cr. Specialty Chemicals and Pharma. Key highlights and FY27 outlook."],"rank_math_focus_keyword":["Vivimed Labs Q4 FY26 results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["102133"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["14445"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/05\/Vivimed-Labs-Q4-FY26-Results.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/101678","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=101678"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/101678\/revisions"}],"predecessor-version":[{"id":102135,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/101678\/revisions\/102135"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/102133"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=101678"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=101678"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=101678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}